Inventor

RAPECKI STEPHEN EDWARD

GB28 patents

⚠️ This page may combine multiple inventors who share the name “RAPECKI STEPHEN EDWARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RAPECKI STEPHEN EDWARD

UCB BIOPHARMA SPRL

Antibody molecules which bind CD22

Molecules with specificity for CD79 and CD22

Bispecific format suitable for use in high-through-put screening

Method employing bispecific antibodies

Antibody molecules which bind CD79

Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

Molecules with specificity for CD45 and CD79

Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17F

Methods of treating an IL-17A mediated pathological condition

Antibody molecules which bind CD45

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

UCB Biopharma SRL

TNF receptor signaling modulator assay

Methods of identifying signaling modulators of the trimeric TNFa

Antibody molecules which bind CD22

Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors

Molecules with specificity for CD79 and CD22

Method of identifying potential inhibitors of APO TNFα trimers

Complexes between CD40 and compounds comprising benzimidazole moieties

Antibody molecules which bind CD22

ADAMS RALPH

Antibody molecules which bind IL-17A and IL-17F

Neutralising antibody molecules having specificity for human IL-17

Nucleic acid molecules encoding neutralising antibodies having specificity for human IL-17

UCB PHARMA SA

Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F

Neutralising antibody molecules having specificity for human IL-17

Method for the treatment of multiple sclerosis by inhibiting IL-17 activity

RAPECKI STEPHEN EDWARD

Antibody molecules which bind to human IL-17

DNA encoding antibody molecules which bind human IL-17